Soleno Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Soleno Therapeutics has a total shareholder equity of $157.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $180.7M and $23.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$169.68m |
| Equity | US$157.51m |
| Total liabilities | US$23.18m |
| Total assets | US$180.69m |
Recent financial health updates
We're Not Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn
Mar 08
Here's Why We're Watching Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation
Sep 20Companies Like Soleno Therapeutics (NASDAQ:SLNO) Could Be Quite Risky
Aug 12Here's Why Soleno Therapeutics (NASDAQ:SLNO) Must Use Its Cash Wisely
May 10We're A Little Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Rate
Jan 24Will Soleno Therapeutics (NASDAQ:SLNO) Spend Its Cash Wisely?
Mar 23Recent updates
We're Not Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn
Mar 08Here's Why We're Watching Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation
Sep 20Soleno sheds 13% as 1-for-15 reverse stock split takes effect
Aug 26Companies Like Soleno Therapeutics (NASDAQ:SLNO) Could Be Quite Risky
Aug 12Soleno Therapeutics surges 49% on regulatory pathway for Prader-Willi syndrome treatment
Jul 20Here's Why Soleno Therapeutics (NASDAQ:SLNO) Must Use Its Cash Wisely
May 10We're A Little Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Rate
Jan 24Soleno shares soar on FDA Orphan Drug status for Glycogen Storage Disease treatment
Jun 02Will Soleno Therapeutics (NASDAQ:SLNO) Spend Its Cash Wisely?
Mar 23Need To Know: Soleno Therapeutics, Inc. (NASDAQ:SLNO) Insiders Have Been Buying Shares
Jan 29
Soleno Therapeutics: Could Be Big Fish In The Small Pond
Jan 08Here's Why We're Not Too Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation
Dec 07Financial Position Analysis
Short Term Liabilities: SLNO's short term assets ($171.4M) exceed its short term liabilities ($11.5M).
Long Term Liabilities: SLNO's short term assets ($171.4M) exceed its long term liabilities ($11.7M).
Debt to Equity History and Analysis
Debt Level: SLNO is debt free.
Reducing Debt: SLNO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SLNO has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if SLNO has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.